Our data adds to increasing evidence that CXCL13 represents a particularly Th17-specific abnormality (8) and positively associates with psoriasis severity (13, 28), nominating it as a clinically useful biomarker for cutaneous disease. The gene discussed is CXCL13; the disease is psoriasis.